|
2021
|
Invention
|
Oxalamide substituted heterocyclic compounds as modulators of the aryl hydrocarbon receptor (ahr)... |
|
2020
|
Invention
|
Clostridioides difficile-associated diseases. Clostridioides difficileClostridioides difficile-as... |
|
2019
|
Invention
|
Isolithocholic acid or isoallolithocholic acid and deuterated derivatives thereof for preventing ... |
|
|
Invention
|
Substituted bicyclic compounds as modulators of the aryl hydrocarbon receptor (ahr). The present ... |
|
2018
|
Invention
|
Aryl hydrocarbon receptor (ahr) modulator compounds.
The present invention relates to 6-amido-1H... |
|
|
Invention
|
Aryl hydrocarbon receptor (ahr) modulator compounds. The present invention relates to 6-amido-1H-... |
|
|
Invention
|
Aryl hydrocarbon receptor (ahr) modulator compounds. The present invention relates to compounds w... |
|
2013
|
Invention
|
Carboxamide or sulfonamide substituted nitrogen-containing 5-membered heterocycles as modulators ... |
|
|
Invention
|
Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the or... |
|
2012
|
Invention
|
Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (... |
|
|
Invention
|
Seven-membered sulfonamides as modulators of rar-related orphan receptor-gamma (rorγ, nr1f3). The... |
|
|
Invention
|
Farnesoid x receptor agonists for cancer treatment and prevention. Provided is a Farnesoid X Rece... |
|
|
Invention
|
Novel fxr (nr1h4) binding and activity modulating compounds. The present invention relates to com... |
|
|
Invention
|
Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor rar-related orphan recept... |
|
2011
|
Invention
|
Compounds for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (rorγ, nr1f... |
|
|
Invention
|
Novel compounds for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (rorγ... |
|
2010
|
Invention
|
Novel fxr (nr1h4 ) binding and activity modulating compounds. The present invention relates to co... |
|
2009
|
Invention
|
Methods of identification of novel ligands for modulation of orphan nuclear receptor rar-related ... |
|
|
Invention
|
Ligands for modulation of orphan receptor-gamma (nr1f3 ) activity. The invention relates to modul... |
|
|
Invention
|
Heterocyclic cyclopropyl-substituted fxr binding compounds. The present invention relates to comp... |
|
2007
|
Invention
|
Heterocyclic fxr binding compounds.
The present invention relates to compounds which bind to the... |
|
|
Invention
|
Heterocyclic fxr binding compounds. The present invention relates to compounds which bind to the ... |
|
|
Invention
|
Heterocyclic fxr binding compounds. The present invention relates to compounds of formula (I) whi... |
|
2005
|
Invention
|
Novel 2-amino-4-quinazolinones and 2-amino-4-oxoquinazolones as lxr nuclear receptor binding comp... |
|
2003
|
Invention
|
Novel 2-amino-4-oxoquinazolones as lxr nuclear receptor binding compounds with partial agonistic ... |
|
|
Invention
|
Nr3b1 nuclear receptor binding 3-substituted pyrazoles.
The present invention relates to compoun... |
|
|
Invention
|
Nr3b1 nuclear receptor binding 3-substituted pyrazoles. The present invention relates to compound... |
|
|
Invention
|
2-amino-4-quinazolinones as lxr nuclear receptor binding compounds. The present invention r... |
|
|
Invention
|
2-amino-4-quinazolinones as lxr nuclear receptor binding compounds. The present invention relates... |
|
2002
|
Invention
|
Nr1h4 nuclear receptor binding compounds.
The present invention relates to compounds according ... |
|
|
Invention
|
Fxr nr1h4 nuclear receptor binding compounds. The invention provides compounds according to the g... |
|
|
Invention
|
Nr1h4 nuclear receptor binding compounds. The present invention relates to compounds according to... |
